The impact of regulatory action on the co-prescribing of renin-angiotensin system blockers in UK primary care-Reference-Cited by-同舟云学术

The impact of regulatory action on the co-prescribing of renin-angiotensin system blockers in UK primary care

Published:2017-05-11 Issue:7 Volume:26 Page:858-862
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Allen Craig¹^ORCID,Donegan Katherine¹

Affiliation:

1. Vigilance and Risk Management of Medicines Division; Medicines and Healthcare Products Regulatory Agency (MHRA); London UK

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference18 articles.

1. EMA Guideline on good pharmacovigilance practices: module XVI-risk minimisation measures-selection of tools and effectiveness indicators http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000345.jsp

2. Monitoring and evaluating the effect of regulatory action: some recent case studies;Thomson;Ther Innov Regul Sci,2015

3. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials;Makani;BMJ,2013

4. EMA PRAC assessment report: for renin-angiotensin system (RAS)-acting agents. Procedure number: EMEA/H/A-31/1370 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Renin-angiotensin_system_

5. Telmisartan, ramipril, or both in patients at high risk for vascular events;Yusuf;N Engl J Med,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of primary care prescriptions for old and very old hypertensive patients;Turkish Journal of Medical Sciences;2023-01-01

2. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study;BMJ Open;2022-06

3. Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data;European Archives of Psychiatry and Clinical Neuroscience;2022-02-25

4. Good versus poor prescribers: the comparison of prescribing competencies in primary care;Primary Health Care Research & Development;2022

5. Impact of regulatory interventions to restrict the combined use of renin–angiotensin system blockers: A Danish nationwide drug utilisation study;British Journal of Clinical Pharmacology;2021-10-08